Publications
5491 Results
- Journal / Conference
- J Clin Oncol. Apr 10;41(11):2076-2086
- Year
- 2023
- Research Committee(s)
- Lymphoma
- PMID
- PMID36495588
- PMC
- PMC10082254
- Study Number(s)
- S0816
The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium
- Journal / Conference
- Nature Medicine Sep;29(9):2278-2285
- Year
- 2023
- Research Committee(s)
- Melanoma
- PMID
- PMID37592104
- PMC
- PMCID10708907
- Study Number(s)
- S1616
Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial
- Journal / Conference
- JAMA Oncology Oct 1;9(10):1371-1379
- Year
- 2023
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID37590003
- PMC
- PMC10436183
The Medicaid Expansion of the Affordable Care Act and the Participation of Patients with Medicaid in Cancer Clinical Trials
- Journal / Conference
- European Urology Aug 16;S0302-2838(23)03019-1. doi: 10.1016/j.eururo.2023.08.004. Online ahead of print
- Year
- 2023
- Research Committee(s)
- Genitourinary
- PMID
- PMID37596191
- PMC
- PMC10869634
- Study Number(s)
- S1605
Phase II Trial of Atezolizumab in BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer: SWOG S1605
- Journal / Conference
- JAMA Netw Open Aug 1;6(8):e2326546
- Year
- 2023
- Research Committee(s)
- Genitourinary
- PMID
- PMID37526936
- PMC
- PMC10394570
- Study Number(s)
- S1216
Impact of race on treatment outcomes of patients with metastatic castration-sensitive prostate cancer receiving intensified androgen deprivation therapy: A post hoc analysis of the SWOG 1216 phase III trial
- Journal / Conference
- JNCI Cancer Spectrum Aug 31;7(5):pkad055. doi: 10.1093/jncics/pkad055
- Year
- 2023
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID37561111
- PMC
- PMC10471524
- Study Number(s)
- S1912CD
Assessment of Financial Screening and Navigation Capabilities at NCI Community Oncology Clinics
- Journal / Conference
- Pharmacogenomics Aug;24(12):665-673
- Year
- 2023
- Research Committee(s)
- Breast
- PMID
- PMID37615099
- PMC
- PMC10565537
- Study Number(s)
- S0226
Effects of CYP3A4 and CYP2C9 genotype on systemic anastrozole and fulvestrant concentrations in SWOG S0226
- Journal / Conference
- AACR Annual Meeting (April 14-19, 2023, Orlando, FL, poster; Cancer Research Volume 83, Issue 7_Supplement 1 April 2023
- Year
- 2023
- Research Committee(s)
- Melanoma
- Study Number(s)
- S1607
Combination of talimogene laherparepvec (T-VEC) with pembrolizumab (pembro) in advanced melanoma patients following progression on a prior PD-1 inhibitor: SWOG S1607
- Journal / Conference
- JCO Precision Oncology Sep;7:e2300218
- Year
- 2023
- Research Committee(s)
- Lung
- PMID
- PMID37677122
- Study Number(s)
- LUNGMAP
Representativeness of Patients Enrolled in the Lung Cancer Master Protocol (Lung-MAP)
- Journal / Conference
- WCLC (September 9 to 12, 2023, Singapore), oral presentation #OA12.03
- Year
- 2023
- Research Committee(s)
- Lung